PTC Therapeutics Inc’s recently made public that its Director ZELDIS JEROME B unloaded Company’s shares for reported $0.76 million on May 22 ’24. In the deal valued at $38.24 per share,20,000 shares were sold. As a result of this transaction, ZELDIS JEROME B now holds 14,500 shares worth roughly $0.53 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Golden Lee Scott sold 175 shares, generating $5,744 in total proceeds. Upon selling the shares at $32.82, the EVP & CHIEF MEDICAL OFFICER now owns 59,813 shares.
Before that, Klein Matthew B. sold 3,361 shares. PTC Therapeutics Inc shares valued at $83,669 were divested by the CHIEF EXECUTIVE OFFICER at a price of $24.89 per share. As a result of the transaction, Klein Matthew B. now holds 225,807 shares, worth roughly $8.25 million.
Raymond James upgraded its PTC Therapeutics Inc [PTCT] rating to a Mkt perform from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in mid December from “an Equal-weight” to “an Underweight”. Wells Fargo began covering PTCT with “an Overweight” recommendation on December 08, 2023. Oppenheimer revised its rating on October 30, 2023. It rated PTCT as “an Outperform” which previously was an “a Perform”.
Price Performance Review of PTCT
On Friday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock fall -1.11% to $36.52. Over the last five days, the stock has gained 0.44%. PTC Therapeutics Inc shares have risen nearly 32.51% since the year began. Nevertheless, the stocks have fallen -16.20% over the past one year. While a 52-week high of $45.68 was reached on 05/21/24, a 52-week low of $17.53 was recorded on 02/13/24. SMA at 50 days reached $31.45, while 200 days put it at $27.97. A total of 0.54 million shares were traded, compared to the trading of 0.62 million shares in the previous session.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 36.06, which if violated will result in even more drops to 35.61. On the upside, there is a resistance level at 37.13. A further resistance level may holdings at 37.75. The Relative Strength Index (RSI) on the 14-day chart is 56.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.80%. Stochastics %K at 48.87% indicates the stock is a holding.
